Home Journal Papers Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 

Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 

2509
0
Advertisement

Amniogenesis—the development of amnion—is a critical developmental milestone for early human embryogenesis and successful pregnancy1, 2. However, human amniogenesis is poorly understood due to limited accessibility to peri-implantation embryos and a lack of in vitro models. Here we report an efficient biomaterial system to generate human amnion-like tissue in vitro through self-organized development of human pluripotent stem cells (hPSCs) in a bioengineered niche mimicking the in vivo implantation environment. We show that biophysical niche factors act as a switch to toggle hPSC self-renewal versus amniogenesis under self-renewal-permissive biochemical conditions. We identify a unique molecular signature of hPSC-derived amnion-like cells and show that endogenously activated BMP–SMAD signalling is required for the amnion-like tissue development by hPSCs. This study unveils the self-organizing and mechanosensitive nature of human amniogenesis and establishes the first hPSC-based model for investigating peri-implantation human amnion development, thereby helping advance human embryology and reproductive medicine.

Source: Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche : Nature Materials : Nature Research

Previous articleFred Hutch announces $1M in grants to commercialize cutting-edge cancer and HIV research
Next articlePharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers
CellTribune.com provides business and research news updates for the cell and gene therapy industry. CellTribune follows the companies and people who drive innovation in this exciting technology. The goal of CellTribune is to be recognized as the media leader and the go-to source for originally-reported, quality news coverage in this industry. We strive to become the link between budding companies, analysts and institutional investors. Submit your press release to Cell Tribune for immediate publication.